India may get emergency-use authorisation for a coronavirus vaccine from regulators by the end of December or early January, with several candidates now in the final stage of trials, Dr Randeep Guleria, director, All India Institute of Medical Science said on Thursday.
Speaking to ANI, Guleria said that the data showed that in the short term the vaccine is safe. “There is good data available that the vaccines are very safe. Safety and efficacy of vaccines not compromised at all. Around 70,000-80,000 volunteers have been given vaccines in trials with no significant serious adverse effects seen.”
Russia was the first